403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Why Is LNTH Stock Up After Hours?
(MENAFN- AsiaNet News)
Shares of Lantheus Holdings, Inc. (LNTH) rose 5% after hours on Friday after the company announced that the U.S. Food and Drug Administration has approved its PYLARIFY TruVu injection.
The injection is indicated for imaging certain lesions in men with prostate cancer.
It is now expected to be commercially available in the fourth quarter of 2026.
Get updates to this developing story directly on Stocktwits.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment